In addition, TREM2 is a confirmed genetic risk factor for AD [18], and most studies evaluating the association between TREM2 and AD focused on tau pathology and amyloid-β peptide (Aβ) pathology. This evidence concerns the gene MAPT and Alzheimer disease.